PGD objectives
- To reduce the risk of genetic abnormality in an offspring, pregnancy loss or implantation failure in translocation carriers.
- To increase the efficiency of ART by screening the embryos for common aneuploidies. Especially this may be effective in women of advanced age group; in patients having three or more miscarriages in their history; in couples who have had more than two unsuccessful IVF/ICSI treatments, in men with hard spermatogenesis disorders.
- To determine the embryo's sex in order to avoid sex-associated disease in an offspring, if one of the parents is ill.
Ask Question
